We can develop stable cell lines that robustly express FAP, which are essential for our cell-based functional assays. These customized cell lines are critical for providing a more biologically relevant context for your compound testing.
Learn More →Creative Biolabs helps you accelerate drug discovery and confidently advance your lead compounds by providing comprehensive, validated screening and selectivity platforms. Our deliverables go beyond raw numbers, providing a complete profile of your compounds' activity, specificity, and binding kinetics, which are critical for de-risking your pipeline. Through advanced enzymatic, cell-based, and kinetic assays, we help you overcome cross-reactivity issues with homologous proteases like DPP4 and POP.
FAP, a serine protease, is an attractive therapeutic target in oncology and fibrosis due to its high expression in disease states and minimal presence in healthy tissues. This unique expression profile makes it a compelling candidate for developing highly specific therapies that can target diseased cells while sparing healthy ones, thereby minimizing side effects. However, developing such therapies is complex, as FAP's structural similarity to other proteases, particularly Dipeptidyl Peptidase 4 (DPP4) and Prolyl Oligopeptidase (POP), presents a significant challenge.
Discover how we can help - Request a consultation.
| Cellular and Mechanistic Analysis | Biochemical and Histological Readouts |
|---|---|
|
|
Our team provides an unparalleled level of scientific insight. This expertise is a cornerstone of our service, ensuring that every project is guided by professional knowledge and a proven track record.
Our comprehensive, multi-stage workflow de-risks your pipeline by meticulously vetting compounds. This process acts as a scientific funnel, ensuring only the most promising candidates with confirmed on-target activity and minimal off-target effects are advanced.
Our detailed reports provide clear, actionable insights that help you make confident decisions about which compounds to advance. Each report includes the key metrics and a comprehensive interpretation of the results, a proposed mechanism of action, and strategic recommendations.
By providing reliable and efficient services, we have helped numerous researchers and companies achieve significant milestones, including accelerated screening timelines and reduced off-target failures, as demonstrated by our published data and case studies.
Experience the Creative Biolabs advantage - Get a quote today.
Our platform is highly flexible and can accommodate a wide range of compounds, including small molecules, biologics, and natural products. Our HTS protocols are optimized for diverse compound libraries, and we're happy to discuss your specific compound's properties during our initial consultation.
Absolutely. Our service is designed to support the entire drug discovery pipeline. Our advanced binding and kinetic analysis provide the mechanistic insights needed for rational lead optimization, and our team of scientists can help you interpret the data to guide your next steps.
We can develop stable cell lines that robustly express FAP, which are essential for our cell-based functional assays. These customized cell lines are critical for providing a more biologically relevant context for your compound testing.
Learn More →We offer custom services for expressing and purifying high-quality recombinant FAP. Our expertise ensures that the protein is produced with high purity and biological activity, which is essential for obtaining reliable and consistent results in your FAP assays.
Learn More →Ready to advance your precision oncology initiatives? Creative Biolabs is your trusted partner in accelerating FAP-targeted drug discovery. Our expert-led FAP assay portfolio service is designed to provide the specific, reliable data you need to advance your projects with confidence.
Contact us for more information and to discuss your project.